Manipulating the tumour immune microenvironment by N6-methyladenosine RNA modification

Area of Science:

• Epigenetics
• Immunology
• Oncology

Background:

• N6-methyladenosine (m6A) is the most prevalent mRNA epigenetic modification in mammals.
• m6A modifications are critical for immune cell development and function.
• Dysregulation of m6A regulators impacts cancer development and immune evasion.

Purpose of the Study:

• To provide a comprehensive overview of m6A modifications in invasive immune cells.
• To explore the role of m6A in immune regulation within the tumour microenvironment.
• To summarize how m6A epigenetic regulators influence anti-tumour immune responses.

Main Methods:

• Literature review and synthesis of existing research on m6A modifications.
• Analysis of the impact of m6A on immune cell activation and invasion.
• Examination of m6A regulators in the context of tumour immunology.

Main Results:

• m6A-modified enzymes influence tumour progression by modulating immune cell activity.
• m6A regulators in tumour cells affect the anti-tumour immune response.
• m6A modifications play a significant role in shaping the tumour immune microenvironment.

Conclusions:

• m6A modifications are key players in immune cell function and tumour development.
• Targeting m6A pathways presents a promising strategy for novel cancer immunotherapies.
• Further research into m6A is crucial for advancing cancer treatment.